NovoCure Limited
NasdaqGS:NVCR
$ 15.53
$-0.02 (-0.13%)
$ 15.53
$-0.02 (-0.13%)
End-of-day quote: 05/07/2024

NVCR - NovoCure Stock Prediction 2025 - 2030

9 years of reliable NovoCure stock forecast. The Wall Street analysts predict Outperform for NVCR. See at a glance whether NasdaqGS:NVCR will rise in the future.

$0.00
Forecast 2023
$18.01
Forecast 2025
$28.17
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$18.01
Forecast 2030
$28.17
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.49
Price-to-book Ratio
4.65
Market Cap
1.32B
TEV
1.01 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$26.86

NovoCure Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

NovoCure Stock Forecast 2023

$22.00

In the last five quarters, NovoCure’s Price Target has fallen from $94.15 to $26.86 - a -71.47% decrease. Seven analysts predict that NovoCure’s share price will fall in the coming year, reaching $22.00. This would represent a decrease of -18.09%.

41.66%
41.66
Last update: 05/08/2024

Highest Price Target $42.00

Average Price Target $22.00

Lowest Price Target $14.50

NovoCure Stock Forecast 2025

Stock Prediction for the Price of One NovoCure Share in Jan 2025.

In Jan 2025 analysts predict a share price of $16.60. An increase of 6.88% compared to today's share price.

Stock Prediction for the Price of One NovoCure Share in Feb 2025.

In Feb 2025 analysts predict a share price of $16.73. An increase of 7.71% compared to today's share price.

Stock Prediction for the Price of One NovoCure Share in Mar 2025.

In Mar 2025 analysts predict a share price of $16.86. An increase of 8.53% compared to today's share price.

Stock Prediction for the Price of One NovoCure Share in Apr 2025.

In Apr 2025 analysts predict a share price of $16.98. An increase of 9.36% compared to today's share price.

Stock Prediction for the Price of One NovoCure Share in May 2025.

In May 2025 analysts predict a share price of $17.11. An increase of 10.19% compared to today's share price.

Stock Prediction for the Price of One NovoCure Share in Jun 2025.

In Jun 2025 analysts predict a share price of $17.24. An increase of 11.02% compared to today's share price.

Stock Prediction for the Price of One NovoCure Share in Jul 2025.

In Jul 2025 analysts predict a share price of $17.37. An increase of 11.84% compared to today's share price.

Stock Prediction for the Price of One NovoCure Share in Aug 2025.

In Aug 2025 analysts predict a share price of $17.50. An increase of 12.67% compared to today's share price.

Stock Prediction for the Price of One NovoCure Share in Sep 2025.

In Sep 2025 analysts predict a share price of $17.63. An increase of 13.5% compared to today's share price.

Stock Prediction for the Price of One NovoCure Share in Oct 2025.

In Oct 2025 analysts predict a share price of $17.75. An increase of 14.32% compared to today's share price.

Stock Prediction for the Price of One NovoCure Share in Nov 2025.

In Nov 2025 analysts predict a share price of $17.88. An increase of 15.15% compared to today's share price.

Stock Prediction for the Price of One NovoCure Share in Dec 2025.

In Dec 2025 analysts predict a share price of $18.01. An increase of 15.98% compared to today's share price.

NovoCure Stock Predictions 2030

NovoCure Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $25.96. An increase of 67.18% compared to the previous month's estimate.

NovoCure Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $26.16. An increase of 68.48% compared to the previous month's estimate.

NovoCure Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $26.37. An increase of 69.77% compared to the previous month's estimate.

NovoCure Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $26.57. An increase of 71.06% compared to the previous month's estimate.

NovoCure Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $26.77. An increase of 72.36% compared to the previous month's estimate.

NovoCure Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $26.97. An increase of 73.65% compared to the previous month's estimate.

NovoCure Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $27.17. An increase of 74.94% compared to the previous month's estimate.

NovoCure Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $27.37. An increase of 76.24% compared to the previous month's estimate.

NovoCure Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $27.57. An increase of 77.53% compared to the previous month's estimate.

NovoCure Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $27.77. An increase of 78.83% compared to the previous month's estimate.

NovoCure Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $27.97. An increase of 80.12% compared to the previous month's estimate.

NovoCure Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $28.17. An increase of 81.41% compared to the previous month's estimate.

P/E
0.00
Beta
0.49
Price-to-book Ratio
4.65
Market Cap
1.32B
TEV
1.01 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$26.86

NovoCure Analyst Ratings Frequently Asked Questions

Who are the analysts watching NovoCure Limited?

The following analysts have recently covered NovoCure:

Evercore ISI
H.C. Wainwright & Co.
J.P. Morgan
Leerink Partners LLC
Marktfeld
Piper Sandler Companies
Wedbush Securities Inc.
Wells Fargo Securities, LLC
Mirae Asset Securities Co., Ltd.
(This information refers to the last 90 days.)

Who are the sell-side analysts watching NovoCure Limited?

The following sell-side analysts have recently covered NovoCure:

Kumar, Vijay Muniyappa
Bodnar, Emily Claudia
Fye, Jessica Macomber
Chang, Wei Ji
Paraskevopoulos, Michail
Bednar, Jason M.
Nierengarten, David Matthew
Biegelsen, Lawrence H.
Kim, Choong-Hyun
(This information refers to the last 90 days.)